🇺🇸 FDA
Patent

US 6750350

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

expired A61PA61P1/04A61P13/08

Quick answer

US patent 6750350 (Gonadotropin-releasing hormone receptor antagonists and methods relating thereto) held by Neurocrine Biosciences, Inc. expires Mon Jun 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Neurocrine Biosciences, Inc.
Grant date
Tue Jun 15 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61P, A61P1/04, A61P13/08, A61P15/00, A61P15/08